Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

John J. Harrington net worth and biography

John Harrington Biography and Net Worth

EVP of Athersys

Dr. Harrington co-founded Athersys in 1995 and has served as our Chief Scientific Officer, Executive Vice President and Director since our founding. Dr. Harrington led the development of the RAGE® technology, as well as its application for gene discovery, drug discovery and commercial protein production applications. He is a listed inventor on over 20 issued or pending United States patents, has authored numerous scientific publications, and has received numerous awards for his work, including being named one of the top international young scientists by MIT Technology Review in 2002. Dr. Harrington has overseen the therapeutic product development programs at Athersys since their inception and is also focused on the clinical development and manufacturing of MultiStem®. During his career, he has also held positions at Amgen and Scripps Clinic. He received his B.A. in Biochemistry and Cell Biology from the University of California at San Diego and his Ph.D. in Cancer Biology from Stanford University School of Medicine.

What is John J. Harrington's net worth?: The estimated net worth of John J. Harrington is at least $3,625.78 as of June 15th, 2021. Dr. Harrington owns 805,728 shares of Athersys stock worth more than $3,626 as of April 25th. This net worth evaluation does not reflect any other assets that Dr. Harrington may own. Learn More about John J. Harrington's net worth.
How do I contact John J. Harrington?: The corporate mailing address for Dr. Harrington and other Athersys executives is 3201 CARNEGIE AVENUE, CLEVELAND OH, 44115. Athersys can also be reached via phone at (216) 431-9900 and via email at [email protected]. Learn More on John J. Harrington's contact information.
Has John J. Harrington been buying or selling shares of Athersys?: John J. Harrington has not been actively trading shares of Athersys during the last quarter. Most recently, John J. Harrington sold 21,050 shares of the business's stock in a transaction on Wednesday, September 15th. The shares were sold at an average price of $1.46, for a transaction totalling $30,733.00. Learn More on John J. Harrington's trading history.
Who are Athersys' active insiders?: Athersys' insider roster includes Laura Campbell (Insider), John Harrington (EVP), Ismail Kola (Director), William Lehmann, Jr. (CEO), and Ivor Macleod (CFO). Learn More on Athersys' active insiders.

John J. Harrington Insider Trading History at Athersys

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/15/2021	Sell	21,050	$1.46	$30,733.00
6/15/2021	Sell	20,767	$1.55	$32,188.85	805,728
6/8/2021	Sell	27,107	$1.75	$47,437.25
3/15/2021	Sell	5,000	$1.97	$9,850.00	740,795
9/15/2020	Sell	5,000	$2.21	$11,050.00	782,718
3/16/2020	Sell	5,000	$1.25	$6,250.00	693,220
12/16/2019	Sell	5,000	$1.24	$6,200.00	720,060
3/15/2019	Sell	15,000	$1.55	$23,250.00	636,218
12/14/2018	Sell	15,000	$1.93	$28,950.00	660,270
9/14/2018	Sell	15,000	$1.91	$28,650.00	684,320
6/15/2018	Sell	15,000	$2.30	$34,500.00	612,503
3/16/2018	Sell	15,000	$1.84	$27,600.00
12/18/2017	Sell	7,500	$1.77	$13,275.00	658,474
12/15/2017	Sell	7,500	$1.68	$12,600.00	658,474
9/18/2017	Sell	15,000	$2.17	$32,550.00	679,416
6/16/2017	Sell	36,000	$1.45	$52,200.00	712,743
12/16/2016	Sell	15,000	$1.60	$24,000.00	599,392
9/16/2016	Sell	15,000	$1.96	$29,400.00	619,639
9/21/2015	Sell	8,150	$1.36	$11,084.00	531,056
6/19/2015	Sell	8,150	$1.23	$10,024.50
9/19/2014	Sell	8,150	$1.41	$11,491.50
6/19/2014	Sell	8,150	$1.63	$13,284.50
3/18/2014	Sell	8,150	$3.54	$28,851.00
9/20/2013	Sell	30,000	$1.82	$54,600.00

John J. Harrington Buying and Selling Activity at Athersys

Athersys Company Overview

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. The company was founded in 1995 and is headquartered in Cleveland, Ohio.

Today's Range

Now: $0.00

$0.00

50 Day Range

MA: $0.01

$0.00

$0.02

2 Week Range

Now: $0.00

$0.01

$1.99

Volume

147,446 shs

Average Volume

1,765,480 shs

Market Capitalization

$277,735.50

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

John Harrington Biography and Net Worth

What is John J. Harrington's net worth?

How do I contact John J. Harrington?

Has John J. Harrington been buying or selling shares of Athersys?

Who are Athersys' active insiders?

John J. Harrington Insider Trading History at Athersys

John J. Harrington Buying and Selling Activity at Athersys

Athersys Company Overview

Today's Range

50 Day Range

2 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta